you have the possibility to publish an article related to the theme of this page, and / or to this region:
Great Britain - -An information and promotions platform.
Links the content with your website for free.
Web content about Covid vaccine - Great Britain
Great Britain
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-Pfizer–BioNTech COVID-19 vaccine
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-Deployment of COVID-19 vaccines
As of 3 January 2024[update], 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Moderna COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-Janssen COVID-19 vaccine
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-History of COVID-19 vaccine development
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-List of COVID-19 vaccine authorizations
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-COVID-19 vaccine misinformation and hesitancy
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Novavax COVID-19 vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-Sputnik V COVID-19 vaccine
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-Sinopharm BIBP COVID-19 vaccine
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-MRNA vaccine
, such as the Pfizer–BioNTech -19 , have the disadvantage of requiring ultracold storage before distribution, other mRNA
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-COVID-19 vaccination in the United Kingdom
Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-COVID-19 vaccination in the United States
public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-Sanofi–GSK COVID-19 vaccine
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-COVID-19 vaccine hesitancy in the United States
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-Operation Warp Speed
and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-Vaccine Maitri
Vaccine Maitri ("Vaccine Friendship") is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-COVID-19 pandemic in the United States
2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-Vaccine passports during the COVID-19 pandemic
and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 pandemic
strains (variants) with varying degrees of infectivity and virulence. COVID-19 vaccines were widely deployed in various countries beginning in December 2020
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-Deaths of anti-vaccine advocates from COVID-19
of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-COVID-19 vaccine card
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received
Great Britain-Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Valneva COVID-19 vaccine
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-COVID-19 vaccination mandates in the United States
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and
Great Britain-CoronaVac
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-COVID-19 vaccination in Canada
distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-Anti-vaccine activism
Anti-vaccine activism, also called the "anti-vax" movement, is organized activity designed to increase vaccine hesitancy, often by disseminating misinformation
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-COVID-19 pandemic in India
India. COVID-19 pandemic death rates by country COVID-19 pandemic in South Asia SAARC COVID-19 Emergency Fund Vaccine Maitri A list of COVID-19 articles
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-Vaccine hesitancy
Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-CoWIN
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-COVID-19 vaccination in the Philippines
2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-Sinopharm COVID-19 vaccine
Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-Vaccine shedding
2021 are live-virus vaccines. Despite this, a COVID-19 "vaccine shedding" conspiracy theory has subsequently emerged, leading to vaccine hesitancy among some
Great Britain-BCG vaccine
Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-Abdala (vaccine)
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This candidate, named
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-CureVac
beginning of the COVID-19 pandemic, CureVac was an early starter in the race to develop a German vaccine for protection against COVID-19, caused by infection
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-COVID-19 vaccination in Japan
Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose. On 14 February 2021
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-COVID-19 vaccination in South Africa
Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. As of 20 October 2021, registration for the COVID-19
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-COVID-19 vaccination in Australia
vaccinated with any available vaccine, including the AstraZeneca COVID-19 Vaccine. This was based on an increased risk of COVID-19 infection and ongoing constraints
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-Embolic and thrombotic events after COVID-19 vaccination
Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the Janssen COVID‑19 vaccine (Johnson & Johnson)
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-COVID-19 vaccination in Israel
of COVID-19 vaccine shots for children between the ages of 5 and 11 years. Israeli epidemiologists and health authorities have identified vaccine hesitancy
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-CureVac COVID-19 vaccine
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-Walvax COVID-19 vaccine
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-MVC COVID-19 vaccine
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-COVID-19 vaccination in mainland China
Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-Aseem Malhotra
Despite initially campaigning for the COVID vaccine, he later campaigned against the use of COVID mRNA vaccines contrary to the available evidence. Malhotra
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-Robert F. Kennedy Jr.
vaccines and autism. Since the onset of the COVID-19 pandemic, he has emerged as a leading proponent of COVID-19 vaccine misinformation in the United States.
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-COVID-19 vaccination in Bangladesh
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-COVID-19 vaccine clinical research
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-COVID-19 vaccination in Romania
campaigns, poor rural infrastructure, and weak vaccine education. The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian: Comitetul
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-COVID-19 pandemic in Australia
first doses of the Pfizer–BioNTech COVID-19 vaccine being administered in Sydney on 21 February 2021. The country's vaccine rollout, which fell short of its
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Vaxart COVID-19 vaccine
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Parliamentary Under-Secretary of State for Public Health, Start for Life and Primary Care
health policy. The office of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was created later and was held by Nadhim Zahawi from 28
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Stemirna COVID-19 vaccine
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-Katalin Karikó
also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Adar Poonawalla
for London because of threats demanding COVID-19 vaccines. Poonawalla also said that he will start COVID vaccine production outside India, in addition to
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Moderna
commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-The Vaccine War
indigenous vaccine at the height of the COVID-19 pandemic in the race against time. The Director General of ICMR Dr. Balram Bhargava spearheads the vaccine development
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-Influenza vaccine
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Vabiotech COVID-19 vaccine
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-History of the COVID-19 pandemic in the United Kingdom
across the UK. The first COVID-19 vaccine was approved and began its rollout in the UK in early December. 15 million vaccine doses had been given to predominantly
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-Viral vector vaccine
response. As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans. The first
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Vaccine misinformation
to vaccination leads to vaccine hesitancy which fuels disease outbreaks. As of 2019, prior to the COVID-19 pandemic, vaccine hesitancy was considered
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Sinopharm WIBP COVID-19 vaccine
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-Corbevax
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-COVID-19 vaccination in Vietnam
vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-COVID-19 vaccination in Africa
2021, the European Investment Bank committed to fund Senegal's first COVID-19 vaccine production factory, at Institut Pasteur de Dakar. By the end of 2022
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-Inovio COVID-19 vaccine
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-Convidecia
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-Serum Institute of India
(Covovax) vaccine for India and other low and middle-income countries. The company will also produce Codagenix's nasally administered COVID-19 vaccine CDX-005
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-Therapeutic Goods Administration
Pfizer COVID-19 vaccine for teenagers between 12 and 15 years old. On 5 December 2021, the TGA provisionally approved the Pfizer COVID-19 vaccine access
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Covaxin
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2021)
-19. Brian Pinker, 82, becomes the first person in the country to receive the Oxford/AstraZeneca as vaccinations using the
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-COVID-19 vaccination in Malaysia
being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021. Despite running smoothly for the most
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-Arcturus COVID-19 vaccine
Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine. If an
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-Minhai COVID-19 vaccine
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-ImmunityBio COVID-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-COVID-19 vaccination in Iran
vaccines. This decision stopped the import and use of Pfizer and Astrazeneca vaccines for a long period during which many Iranians died due to covid.
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-2020
fully tested vaccine, Pfizer–BioNTech COVID-19 vaccine. Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer vaccine after trials
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-Turbo cancer
against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. The myth, spread by a number of vaccine opponents
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-COVID-19 vaccination in New Zealand
primary vaccine, and booster vaccines, is the Pfizer–BioNTech COVID-19 vaccine (and for children, Pfizer pediatric). The Novavax COVID-19 vaccine is also
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-COVID-19 vaccination in Sweden
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-2023 Nobel Prize in Physiology or Medicine
base modifications that enabled the development of effective mRNA vaccines against COVID-19". Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-World Council for Health
Health falsely claiming that COVID-19 vaccines were unsafe. In July 2022, the US-cardiologist Peter McCullough, an anti-vaccine advocate, falsely claimed
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-Inactivated vaccine
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other pathogens that have been grown in culture and
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-COVID-19 vaccination in South Korea
According to JoongAng Ilbo, as of 5 July, the remaining amount of the COVID-19 vaccine is 1.8 million doses, including 1.4 million from Pfizer. On 6 July
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-European Commission–AstraZeneca COVID-19 vaccine dispute
pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-Rockmond Dunbar
'9-1-1' Over Covid Vaccine Mandate After Pursuing Medical & Religious Exemptions". Deadline. "US TV actor Rockmond Dunbar sues Disney over Covid 'discrimination'"
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-COVID-19 vaccination in the Republic of Ireland
doses of the Moderna COVID-19 vaccine. On 15 December, Minister for Health Stephen Donnelly announced the Government's National COVID-19 Vaccination Strategy
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-COVID-19 vaccination in Moldova
Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2021)
travellers who have received the vaccine. As COVID cases rise again, the British Medical Association calls for some COVID restrictions to remain in England
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Drew Weissman
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-Novavax
focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Pfizer
and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-Vaccine Taskforce
Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-Timeline of the COVID-19 pandemic in England (2021)
person to receive the Oxford–AstraZeneca COVID-19 vaccine. 5 January The UK records over 60,000 positive cases of COVID in one day, the highest ever, with over
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-BioNTech
developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which at the time offered a 91% efficacy in preventing confirmed COVID-19 occurring
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-COVID-19 pandemic in Telangana
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 15 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Biological E. Limited
is a major supplier of vaccines to international development and aid organisations such as WHO, UNICEF, BMGF. During the COVID-19 pandemic, the company
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-Sanofi
100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved. As of August 2020, COVID-19 vaccine development in Sanofi
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-GAVI
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-COVID-19 vaccination in Germany
ministry stated that the expenditure on vaccines to date was 13.1 billion euros. There are several COVID-19 vaccines at various stages of development around
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-COVID-19 vaccination in Nigeria
COVID-19 vaccine, and 8,197,832 have received their second dose. On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-The Daily Sceptic
British commentator Toby Young. It has published misinformation about COVID-19 vaccines and climate change denial. Young founded The Daily Sceptic as a successor
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-Children's Health Defense
mainly known for anti-vaccine disinformation, and which has been called one of the main sources of misinformation on vaccines. Founded under the name
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-COVID-19 vaccination in Singapore
14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. On
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-Emergent BioSolutions
typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants;
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Joseph Ladapo
He has attracted attention for promoting vaccine hesitancy and opposing various measures to control COVID-19. After immigrating to the United States
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-AstraZeneca
inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Robert W. Malone
repurposing research. During the COVID-19 pandemic, Malone promoted misinformation about the safety and efficacy of COVID-19 vaccines. Prior to studying medicine
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-West China Hospital COVID-19 vaccine
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-COVAX
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine
Great Britain-Anil Vij
Vij Becomes First Volunteer Of Covid Vaccine Trials". NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij"
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-COVID-19 vaccination in Brazil
Lancet, COVID-19 vaccination in Brazil prevented an additional 1 million deaths from December 8, 2020, to December 8, 2021. Before the Butantan vaccine, Fiocruz
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-2021 in the United Kingdom
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Paul Hudson (businessman)
Institute abandons Covid vaccine" – via www.theguardian.com. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-Sarah Gilbert
vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19
Great Britain-CoviVac (Russia COVID-19 vaccine)
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Timeline of the COVID-19 pandemic in Ghana (2021)
safety protocols as acquiring the vaccine was being worked on, he also claimed there was no case of the new COVID-19 variant in the country. A pastor
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Vaccination
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-COVID-19 vaccination in Switzerland
disease 2019 (COVID-19), in response to the ongoing pandemic in the country. By 14 November 2023, 17,015,053 doses of COVID-19 vaccine have been administered
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-Universal coronavirus vaccine
"National COVID-19 Preparedness Plan", which, in part, discusses plans to "accelerate research and development toward a single COVID vaccine that protects
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-Timeline of the COVID-19 pandemic in New York City
December 14. COVID-19 vaccinations were authorized by the US Food and Drug Administration on December 11. New York administered the vaccine first to health-care
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-Vaccine diplomacy
the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-Sanofi–Translate Bio COVID-19 vaccine
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-One Medical
exchange. During the early stages of vaccine distribution, One Medical was accused of administering the COVID-19 vaccine to ineligible patients in several
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-Bharat Biotech
US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine. In May 2020, Indian Council of Medical Research's (ICMR's) National
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-Soberana 02
name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-COVID-19 vaccination in Ukraine
towards vaccines in Ukraine was widespread prior to the COVID-19 pandemic. Responding to a 2019 survey, only 29% of Ukrainians said vaccines were safe
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)
November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Retrieved 9 November 2020. "Covid vaccine: Boris Johnson warns
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Chinese Academy of Medical Sciences COVID-19 vaccine
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-COVID-19 vaccination in Taiwan
said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose. As
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-Joana Amaral Dias
of the main covid vaccine critics, she has made several false or decontextualized statements. She has asserted that the Covid-19 vaccine does not reduce
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-Sinopharm (company)
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Kizzmekia Corbett
was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-The Exposé
in 2020 by Jonathan Allen-Walker. It is known for publishing COVID-19 and anti-vaccine misinformation. The website became known internationally after
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Timeline of the COVID-19 pandemic in England (2022)
required to take a pre-departure COVID test before travelling abroad, while anyone arriving in England who has had both vaccines is not required to self-isolate
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-List of vaccine excipients
vaccines. "Vaccine Excipient & Media Summary" (PDF). Juan C. Ravell (January 11, 2021). "A Simple Breakdown of the Ingredients in the COVID Vaccines"
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Medicines and Healthcare products Regulatory Agency
approve an RNA vaccine when it gave conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-ZyCoV-D
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-Sinovac Biotech
commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Academy of Military Medical Sciences
Clinical Trials of COVID-19 Vaccine". Voice of America. Retrieved 18 April 2020. "The Lancet: First human trial of COVID-19 vaccine finds it is safe and
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-QazCovid-in
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-COVID-19 vaccination in Nepal
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Andrew Bridgen
had the whip suspended in January after criticising the efficacy of COVID-19 vaccines and claiming that an Israeli cardiologist told him it constitutes
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-V451 vaccine
was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-America's Frontline Doctors
AFLDS shifted to anti-vaccine activism with the rollout of COVID-19 vaccines; the group made false claims about the vaccines' efficacy and safety, and
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-INCOVACC
iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-COVID-19 pandemic in Jammu and Kashmir
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 16 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-COVID-19 vaccination in Russia
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-COVID-19 pandemic in Canada
Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Michael Yeadon
anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Christiane Northrup
medicine and anti-vaccine conspiracy theories. She has a history of opposing vaccination and has embraced QAnon ideology during the COVID-19 pandemic. Northrup
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-John Campbell (YouTuber)
the use of ivermectin as a COVID-19 treatment, and providing misleading commentary about the safety of COVID-19 vaccines. As of March 2024[update], his
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Breakthrough infection
vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine.
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Conjugate vaccine
A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Chinese government response to COVID-19
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Kate Bingham
In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom. Bingham
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Timeline of the COVID-19 pandemic in Scotland (2021)
issued for breach of COVID rules over the New Year. 6 January – Figures have shown that 92,188 people have received a COVID vaccine in Scotland since 8
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-COVID-19 pandemic by country and territory
and percentage of people who have received at least one dose of a COVID-19 vaccine (unless noted otherwise). May include vaccination of non-citizens,
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-Joshua Kimmich
center of COVID vaccine debate". AP NEWS. 25 October 2021. Retrieved 19 November 2021. "Bayern player Kimmich back in quarantine amid vaccine debate".
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Died Suddenly
Stew Peters, a far-right and alt-right anti-vaccine activist. It promotes false claims about COVID-19 vaccines and Great Reset conspiracy theories. The film
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-COVID-19
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-COVID-19 pandemic in Himachal Pradesh
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 10 January 2022. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-HPV vaccine
papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-COVID-19 pandemic in the Republic of Ireland
receive Covid-19 vaccine in Republic of Ireland". Irish Independent. Retrieved 29 December 2020. "'No moves' to shift teachers further up vaccine list"
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-Access to COVID-19 Tools Accelerator
Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-COVID-19 vaccination in Ontario
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer vaccine were administered. In February 2021, shipments for both
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-COVID-19 pandemic in Chhattisgarh
crossed 1.75 billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic "Covid-19 in Chhattisgarh". Covid-19 India. Retrieved
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-Subunit vaccine
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-COVID-19 pandemic in Vietnam
công vaccine Covid-19 Việt Nam. VnExpress. 7 May 2020 Vaccine Covid-19 của Việt Nam sinh miễn dịch cao. VnExpress. 26 June 2020 "Kỳ vọng vắc xin Covid-19
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-Wayne Kent Taylor
improvement from an experimental treatment, "Taylor went to get his COVID vaccine and the tinnitus came roaring back. Two days later [...]" he died by
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-Sinopharm Group
BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Janssen Vaccines
to Janssen Vaccines. Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Grand River Aseptic Manufacturing
Michigan's Grand River to help with COVID-19 vaccine finishing work". "U.S. facility to help fill HHS monkeypox vaccine order". American Hospital Association
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-Sinopharm CNBG COVID-19 vaccine
Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-COVID-19 pandemic in Israel
Pfizer–BioNTech COVID-19 vaccine. 10 million doses of the Oxford–AstraZeneca COVID-19 vaccine. 6 million doses of the Moderna COVID-19 vaccine. Israel was
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-COVID-19 vaccination in Quebec
effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. Priority vaccination
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-SARS-CoV-2 Beta variant
Oxford–AstraZeneca COVID-19 vaccine (AZD1222) against the Beta variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal
Great Britain-COVID-19 pandemic in Haryana
billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic in Rohtak Timeline of the COVID-19 pandemic in India COVID-19
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-SARS-CoV-2 Beta variant
Oxford–AstraZeneca COVID-19 vaccine (AZD1222) against the Beta variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Sinopharm CNBG COVID-19 vaccine
Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-Mislav Kolakušić
investigation to find any causal link between the reports and the COVID-19 vaccine. In March 2022, Kolakušić gave a speech at the European Parliament
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-Nadhim Zahawi
additional responsibility for the COVID-19 vaccination programme as Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment. In the 2021 cabinet
Great Britain-Halal
becomes UK's first to offer Covid vaccine". BBC News. 21 January 2021. Paddock, Richard C. (5 January 2021). "Is the Vaccine Halal? Indonesians Await the
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-COVI-VAC (U.S. COVID-19 vaccine)
COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-Timeline of the COVID-19 pandemic in Northern Ireland (2021)
further 3,500 positive COVID tests and 26 deaths in the most recent 48 hours. 4 January – Rollout of the Oxford/AstraZeneca vaccine begins in Northern Ireland
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Young Americans for Liberty
Orwell novel." In May 2021, YAL helped organize a protest against the COVID-19 vaccine requirement at Rutgers University. Organized by Rutgers junior and
Great Britain-KakaoTalk
South Korean government relaxed COVID-19 laws, KakaoTalk effectively functioned as one of South Korea's digital vaccine passport platforms (along with
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-SARS-CoV-2 Beta variant
Oxford–AstraZeneca COVID-19 vaccine (AZD1222) against the Beta variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-SARS-CoV-2 Beta variant
Oxford–AstraZeneca COVID-19 vaccine (AZD1222) against the Beta variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal
Great Britain-COVID-19 pandemic in Haryana
billion Covid vaccines milestone in the country. COVID-19 pandemic in India COVID-19 pandemic in Rohtak Timeline of the COVID-19 pandemic in India COVID-19
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-COVID-19 pandemic in Uttarakhand
administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021. "India crosses 1.5 bn Covid vaccine doses, Modi terms
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-Sinopharm CNBG COVID-19 vaccine
Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI
Great Britain-Mislav Kolakušić
investigation to find any causal link between the reports and the COVID-19 vaccine. In March 2022, Kolakušić gave a speech at the European Parliament
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-Sinopharm CNBG COVID-19 vaccine
Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI
Great Britain-COVIran Barekat
COVIran Barekat (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Endemic COVID-19
COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot
Great Britain-COVI-VAC (U.S. COVID-19 vaccine)
COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-SARS-CoV-2 Omicron variant
subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused
Great Britain-Timeline of the COVID-19 pandemic in the Republic of Ireland (2021)
Oxford–AstraZeneca COVID-19 vaccine as discussions to secure early delivery of the vaccine got underway. 18 January – The number of patients with COVID-19 being
Great Britain-Sinopharm CNBG COVID-19 vaccine
Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Albert Bourla
Pfizer's vaccine division to focus on Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes
Great Britain-Ali Campbell
21 December 2018. "UB40 vocalist Matt Hoy forced to quit band over Covid vaccine concerns". Retropopmagazine.com. 2 July 2021. "Matt Hoy – Making Music
Great Britain-SARS-CoV-2 Beta variant
Oxford–AstraZeneca COVID-19 vaccine (AZD1222) against the Beta variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal
Great Britain-Nathan Wesenberg
to the Minnesota Senate in January 2020, Wesenberg spoke at an anti COVID vaccine rally at the state Capitol. Wesenberg suggested that Governor Tim Walz
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-COVI-VAC (U.S. COVID-19 vaccine)
COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving
Great Britain-Sinopharm CNBG COVID-19 vaccine
Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-COVID-19 vaccination in France
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According
Great Britain-ZF2001
trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute
Great Britain-Respiratory syncytial virus vaccine
RSV vaccine continued for decades; a 2013 study led to the approved vaccines. Work on RSV vaccines also supported the rapid development of COVID-19 vaccines
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-Nasal vaccine
created nasal COVID-19 vaccines.[citation needed] Nasal vaccines are a subsection of mucosal immunization as they use a mucosal route for vaccine delivery
Great Britain-SARS-CoV-2 Beta variant
Oxford–AstraZeneca COVID-19 vaccine (AZD1222) against the Beta variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal
Great Britain-Mislav Kolakušić
investigation to find any causal link between the reports and the COVID-19 vaccine. In March 2022, Kolakušić gave a speech at the European Parliament
Great Britain-Nathan Wesenberg
to the Minnesota Senate in January 2020, Wesenberg spoke at an anti COVID vaccine rally at the state Capitol. Wesenberg suggested that Governor Tim Walz